Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation

NCT00139568 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00139568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00139568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2005
Completion date
October 31, 2005
Enrollment
600
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation